Prediagnosis Insights Into Amyotrophic Lateral Sclerosis: Clinical Symptoms and Medication Use
Journal of Cachexia, Sarcopenia and Muscle · 2025
DOI: 10.1002/jcsm.70003 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Cachexia, Sarcopenia and Muscle, 2025. Verfasst von Chunyang Pang und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Rehabilitation Medicine, First Affiliated Hospital of Wenzhou Medical University, Wenzhou, China. Hauptthemen laut MEDLINE: Amyotrophic Lateral Sclerosis. Die Arbeit nennt 37 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, Natural Science Foundation of Zhejiang Province.
Abstract (Originalsprache)
Background
Amyotrophic lateral sclerosis (ALS) has a prolonged latency period, though its preclinical characteristics remain poorly understood. This study uses UK Biobank data to explore and compare ALS's pre‐diagnostic features, including symptoms and medication use, aiming to provide insights into the disease's underlying mechanisms.
Methods
Clinical symptoms and medications were identified from self‐reports, hospital records, and death registry data. Propensity score matching was used to match ALS with Alzheimer's disease ( AD ) and Parkinson's disease (PD), ensuring balance in socioeconomic factors to compare symptoms 0–5 years before diagnosis. Cox regression analysis was applied to assess the associations between medication use and the risk of incident ALS and mortality after ALS diagnosis.
Results
A total of 753 ALS cases were observed in 502 417 participants, with an incidence rate of 10.58 per 100 000 person‐years. In the ALS cohort, the male‐to‐female ratio was 2.9, with a median age at onset of 64.61 years (Interquartile range (IQR): 56.80–71.31) and a median survival time post‐diagnosis of 9.08 months (IQR: 3.18–18.98), while females (log‐rank p = 0.038) and individuals with earlier (< 64.61 years) disease onset (log‐rank p < 0.001) had longer survival periods. In the 5 years prior to diagnosis, ALS showed a higher incidence of falls compared to ad (11.3% vs. 3.2%, p < 0.001), but a lower incidence than PD (10.7% vs. 28.3%, p < 0.001). Additionally, ALS had a lower incidence of depression (4.6% vs. 25.6%, p < 0.001), anxiety (3.5% vs. 18.1%, p < 0.001), sleep disorders (1.4% vs. 7.2%, p < 0.001), hypotension (3.4% vs. 30.5%, p < 0.001), constipation (0.3% vs. 4.9%, p < 0.001), and urinary dysfunction (2.2% vs. 8.7%, p < 0.001) compared with PD. The use of calcium channel blockers may be a risk factor for incident ALS (adjusted HR 1.61, 95% CI: 1.22–2.12, p < 0.001).
Conclusions
Pre‐diagnostic presentations of falls are more frequent in ALS than in AD , but less frequent than in PD. However, ALS exhibits fewer psychiatric symptoms and autonomic dysfunction compared with PD. The use of calcium channel blockers may be associated with an increased risk of developing ALS in the future.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Rehabilitation Medicine, First Affiliated Hospital of Wenzhou Medical University, Wenzhou, China.
- Department of Neurology, First Affiliated Hospital of Wenzhou Medical University, Wenzhou, China.
- Department of Neurology, Peking University Third Hospital, Beijing, China.
- Department of Neurology, Shanghai East Hospital, School of Medicine, Tongji University, Shanghai, China.
- Department of Pediatrics, Second Affiliated Hospital and Yuying Children's Hospital of Wenzhou Medical University, Wenzhou, China.
ORCID-Profile: Binbin Deng
Förderung
- National Natural Science Foundation of China
- Natural Science Foundation of Zhejiang Province
Zitieren
APA
Pang, C., Cao, W., Xie, J., Li, Y., Zhu, L., Yu, H., Fan, D., & Deng, B. (2025). Prediagnosis Insights Into Amyotrophic Lateral Sclerosis: Clinical Symptoms and Medication Use. Journal of Cachexia, Sarcopenia and Muscle. https://doi.org/10.1002/jcsm.70003
Vancouver
Pang C, Cao W, Xie J, Li Y, Zhu L, Yu H, et al. Prediagnosis Insights Into Amyotrophic Lateral Sclerosis: Clinical Symptoms and Medication Use. Journal of Cachexia, Sarcopenia and Muscle. 2025. doi:10.1002/jcsm.70003
BibTeX
@article{Pang2025,
author = {Pang, Chunyang and Cao, Wen and Xie, Jiali and Li, Yaojia and Zhu, Luyi and Yu, Huan and Fan, Dongsheng and Deng, Binbin},
title = {Prediagnosis Insights Into Amyotrophic Lateral Sclerosis: Clinical Symptoms and Medication Use},
journal = {Journal of Cachexia, Sarcopenia and Muscle},
year = {2025},
doi = {10.1002/jcsm.70003}
}
EUVIMED